Cholesterol esterification blockade boosts immunotherapy and reduces liver cancer relapse
Yange Gu, Lulu Zhang, Jianhua Li, Ensi Ma, Weiwei Hu, Xiaocheng Du, Feifei Zhang, Tiange Yang, Linyue Bian, Yitian Jin, Yun Liu, Yinghua Wang, Zihan Ning, Chune Yu, Dun Li, , Guangchuan Wang
This study identifies SOAT1 as a target for improving immunotherapy and reducing liver cancer relapse by blocking cholesterol esterification.
bioRxiv · Oct 15, 2025 · PreprintImmunology